Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 539 20 Master Bottle Label Approval Rev A 01 21)

Label (51655 539 20 Master Bottle Label Approval   Rev A 01 21)
Label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg, showing a bottle containing 20 film-coated tablets. The label includes storage instructions, manufacturer Northwind Pharmaceuticals, and repackager Northwind Health Company, LLC. The product is Rx only and stored at controlled room temperature.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride showing its tricyclic ring system and the side chain with hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.